Search results
Bitcoin Price Prediction: As Bernstein Says BTC And ETH ETF Markets Will Hit $450 Billion, The 99BTC...
Inside Bitcoins· 3 hours agoThe Bitcoin price dropped 1.2% in the last 24 hours to trade at $67,760 as of 7:25 a.m. EST, despite...
Hedging Trade: Buying Puts on the S&P 500
Zacks via Yahoo Finance· 3 hours agoBelow you can see that I have measured out a 50% retracement of the most recent leg higher, which is a simple method for identifying a pullback level....
Small Cap Summer: 3 Top Ranked Stocks to Buy Now
Zacks via Yahoo Finance· 24 hours agoIs it time for Small Caps to play catchup? Watch the Russell 2000 Small-Cap Index. But MoneyLion, PubMatic and Universal Technical Institute are strong...
Chainlink price hits 6-week high, is $20 LINK the next stop?
The Cointelegraph· 5 days agoChainlink (LINK) price gained 7% on May 24, despite a downturn in the wider cryptocurrency market. According to a May 24 X post by market intelligence firm Santiment, on-chain metrics are painting ...
Orange juice price analysis: expect juicy returns ahead | Invezz
Invezz· 14 hours agoOrange juice price continued its bullish momentum this week as investors focused on the changing...
Very bad news for the vulnerable Porsche stock price | Invezz
Invezz· 2 days agoPorsche AG (P911) share price is in deep trouble and the situation could worsen in the coming weeks...
Shiba Inu Holders Pivot to New ICO, Aiming for 1000% Gains
Cryptonews· 2 days agoPopular ERC-20 meme coin Shiba Inu ($SHIB) is outperforming Bitcoin, Ethereum and top meme coin...
Strategies for Building Your Small Business
Kinston Free Press· 13 hours agoClick here to view this image from Kinston.com.
Crypto for Gamers: Will $IMX, $BEAM, $GALA, $AXS, $EGLD See Action This Summer?
Investing.com· 13 hours agoIMX price retraced 8.14% this week, with support at $2.27. GALA’s intra-day support was established...
Ocugen stock price analysis: good progress but a risky pattern forms | Invezz
Invezz· 1 hour agoOcugen (NASDAQ: OCGN) stock price is doing well this year as investors focus on its ongoing drug...
